Karuna Therapeutics, Inc.

RHUMBLINE ADVISERS

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/8/2024

Shares

47,175

Value ($000)

14,931

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/8/2024	14,931	0.0%	47,175	12/31/2023
2023 Q3	11/9/2023	8,030	0.0%	47,487	9/30/2023
2023 Q2	8/8/2023	10,216	0.0%	47,113	6/30/2023
2023 Q1	5/11/2023	7,985	0.0%	43,958	3/31/2023
2022 Q4	2/14/2023	8,261	0.0%	42,041	12/31/2022
2022 Q3	11/10/2022	9,023	0.0%	40,113	9/30/2022
2022 Q2	8/11/2022	3,930	0.0%	31,065	6/30/2022
2022 Q1	5/12/2022	2,926	0.0%	23,080	3/31/2022
2021 Q4	2/10/2022	2,936	0.0%	22,411	12/31/2021
2021 Q3	11/12/2021	2,771	0.0%	22,650	9/30/2021
2021 Q2	8/5/2021	2,520	0.0%	22,111	6/30/2021
2021 Q1	5/6/2021	2,207	0.0%	18,355	3/31/2021
2020 Q4	2/10/2021	2,031	0.0%	19,988	12/31/2020
2020 Q3	11/12/2020	1,531	0.0%	19,798	9/30/2020
2020 Q2	8/13/2020	2,544	0.0%	22,827	6/30/2020
2020 Q1	5/6/2020	1,005	0.0%	13,957	3/31/2020
2019 Q4	2/5/2020	378	0.0%	5,014	12/31/2019